Correlation of HER-2 status with immuhistochemical markers and histopathologic features in invasive breast carcinomas

被引：0
|
作者：
Aschie, M. [1 ]
Mitroi, A. [1 ]
Poinareanu, I. [1 ]
Enciu, M. [1 ]
机构：
[1] Pathology, Constanta, Romania
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [21] Change of HER-2/neu status in a subset of distant metastases from breast carcinomas
    Regitnig, P
    Schippinger, W
    Lindbauer, M
    Samonigg, H
    Lax, SF
    JOURNAL OF PATHOLOGY, 2004, 203 (04): : 918 - 926
  • [22] Reliability of HER2 immunohistochemistry in invasive breast carcinomas with micropapillary features
    Alkanat, N. E.
    Atakishieva, L.
    Kadylbek, Z.
    Uner, A.
    Kosemehmetoglu, K.
    VIRCHOWS ARCHIV, 2019, 475 : S64 - S64
  • [23] Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas - Correlation with oncogene amplification in 160 cases
    Gancberg, D
    Lespagnard, L
    Rouas, G
    Paesmans, M
    Piccart, M
    Di Leo, A
    Nogaret, JM
    Hertens, D
    Verhest, A
    Larsimont, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (05) : 675 - 682
  • [24] The status of c-erbB-2/HER-2/neu and expression of E-cadherin in invasive lobular and ductal carcinomas of the breast
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 361 - 361
  • [25] Evaluating the HER-2 status of breast cancer using mammography radiomics features
    Zhou, Jing
    Tan, Hongna
    Bai, Yan
    Li, Jie
    Lu, Qing
    Chen, Rushi
    Zhang, Menghuan
    Feng, Qin
    Wang, Meiyun
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 121
  • [26] HER-2 protein concentrations in breast cancer tissue and correlation to clinical disease markers
    Aalund, Olsen Dorte
    Ostergaard, B.
    Wamberg, P.
    Bokmand, S.
    Jakobsen, E.
    Brandslund, I
    TUMOR BIOLOGY, 2006, 27 : 61 - 61
  • [27] Correlation between immunohistochemistry and FISH for HER-2 in 441 breast carcinomas from multiple hospitals
    Dowsett, M
    Ellis, IO
    Bartlett, JMS
    Salter, J
    Lowe, F
    Wencyk, PM
    Pinder, SE
    Paish, C
    Bell, JA
    Walters, AD
    Cooke, TG
    JOURNAL OF PATHOLOGY, 2001, 195 : 5A - 5A
  • [28] Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining
    Lewis, JT
    Ketterling, RP
    Halling, KC
    Reynolds, C
    Jenkins, RB
    Visscher, DW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (02) : 273 - 281
  • [29] Application of the AMeX method to the evaluation of HER-2 status in breast carcinomas: Comparison with the results of HercepTest
    Mizogami, M
    Sakurai, S
    Kikuchi, M
    Ohta, K
    Sakurai, T
    Tanaka, A
    Saito, K
    PATHOLOGY INTERNATIONAL, 2003, 53 (01) : 27 - 29
  • [30] Immunoexpression of HER2 pathway related markers in HER2 invasive breast carcinomas treated with trastuzumab
    Franco, Andreia Fabiana do Vale
    Malinverni, Andrea Cristina Moraes
    Waitzberg, Angela Flavia Logullo
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 252
12345